Logo
Home
Company ProfileBoards & StaffsMemberships & PartnersAcademy of JournalismCareersBlog(EN)Contact Us
Our JournalsInstruction for AuthorsBrieflands PoliciesPublish My ResearchJournal Management SystemArticle Processing ChargesOpen Peer ReviewPublishing Services
Publish My Book
  1. Brieflands
  2. journals
  3. Zahedan Journal of Research in Medical Sciences
  4. Articles

  5. Inhibitory Effect of Biologically Synthesized Silver Nanoparticle on Growth and Virulence of E. coli
  6. Scopus by Title (Ref)

Zahedan Journal of Research in Medical Sciences

The Official Journal of Zahedan University of Medical Sciences

Home
Current IssueAll IssuesIn Press ArticlesAccepted ManuscriptsSearch
Instructions
Journal InformationBoards and CommitteesIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Malpractice StatementReviewer and AE Registration FormSupportContact Us
APC
Authors GuideSubmit Manuscript

Scopus by Title (Ref)


1. Antimicrobial resistance of salmonella enteritidis and salmonella typhimurium isolated from laying hens, table eggs, and humans with respect to antimicrobial activity of biosynthesized silver nanoparticles

- Elez R.M.M.A. , et al.

2. Cytotoxic effect of green silver nanoparticles against ampicillin-resistantKlebsiella pneumoniae

- Hamida R.S. , et al.

3. Novel Biogenic Silver Nanoparticle-Induced Reactive Oxygen Species Inhibit the Biofilm Formation and Virulence Activities of Methicillin-Resistant Staphylococcus aureus (MRSA) Strain

- Hamida R.S. , et al.

HomeInstructionsAPC

Articles

  • Current Issue
  • All Issues
  • In Press Articles
  • Accepted Manuscripts
  • Search

About Journal

  • Journal Information
  • Boards and Committees
  • Indexing and Listing Sources
  • Journal Metrics
  • Open Peer Review (OPR)
  • Publication Ethics and Malpractice Statement
  • Reviewer and AE Registration Form
  • Support
  • Contact Us
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.